Core Viewpoint - ANGKOR RESOURCES CORP. is advancing its oil and gas exploration efforts in Cambodia through its subsidiary EnerCam Resources Co. Ltd., with a focus on Block VIII, where a 350-kilometer 2-D seismic line program has been established to identify drilling targets and enhance exploration activities [1][2][3]. Group 1: Exploration Activities - The technical team has identified six potential sedimentary sub basins of interest within Block VIII, with four located in the central west and two in the east [2]. - Initial seismic survey targets are concentrated in the western half of the Permit Block, specifically in the South Cardamom, Central Bokor, South Bokor, and North Phu Quoc sedimentary sub basins [3]. - The eastern side of Block VIII features two shallower sedimentary basins, North Kampot and South Kampot, which have known oil seeps of interest [4]. Group 2: Seismic Program and Methodology - The seismic program is expected to be conducted using accelerated weight drop (AWD) seismic technology, particularly suited for the shallower targets identified [4]. - The results from the 2-D seismic survey will be processed and interpreted during the rainy season, guiding subsequent exploration steps [11]. Group 3: Regional Context and Comparisons - The oil seeps found in Block VIII are similar to those in the Phitsanulok Basin of northwestern Thailand, which hosts the Sirikit oilfield, the largest onshore oilfield in Thailand with an initial estimate of 800 million barrels of oil [5]. - The Sirikit oilfield's recoverable estimates include 148 million barrels of oil and 250 billion cubic feet of associated gas, although these figures do not directly indicate the resource potential of Block VIII [5]. Group 4: Environmental Considerations - The seismic lines will be adjusted to remain within Permit boundaries, avoiding any encroachment into Protected Park areas or special Ecological Reserve lands [8].

Company Overview - Rockland Resources Ltd. has acquired the Claybank Beryllium Project in Juab County, Utah, which is strategically located near the largest global beryllium producer, Materion Corp's Spor Mountain [1][11] - The acquisition strengthens Rockland's position in the niche global beryllium market, aligning with the growing global demand for beryllium [2][11] Project Details - The Claybank Beryllium Project consists of two unpatented claims covering approximately 16 hectares (40 acres) [3] - Historical drilling in 1987 identified a beryllium mineralization zone approximately 70 meters long, with drillhole intercepts ranging from 0.25% to 0.65% Be [3][7] - A spring reconnaissance surface sampling and mapping program will commence once weather conditions allow [7] Acquisition Terms - The acquisition was finalized on March 19, 2025, involving cumulative cash payments of $400,000 USD and the issuance of one million warrants at $0.15 CAD [8] - A 2.5% Net Smelter Return (NSR) will be granted to the vendor, with an option for Rockland to buy back 1% for $1 million USD [8] Future Plans - The company plans to confirm historical results at Claybank with the intent to expand the historic mineralized zone [2][11] - Rockland has also set 25,000 options for a consultant at $0.15 for a period of two years [9]

  Rouyn Noranda, Q.C., March 13, 2025 – TheNewswire – Granada Gold Mine Inc. (TSXV: GGM) (OTC: GBBFF) (Frankfurt: B6D) (the "Company" or "Granada") announces that the 2025 Annual General Meeting was held today, Thursday March 13, 2025 and is pleased to report that all resolutions proposed to the Shareholders were approved with over 93.87% voting in favour in all categories.   The resolutions approved are as follows: 1.        The following individuals were re-elected Directors of the Company: Frank J. Basa ...

Core Viewpoint - Metasphere Labs Inc. is planning to hold its annual general and special meeting (AGSM) on April 2, 2025, where it will seek shareholder approval for a proposed share consolidation and a non-brokered private placement [1][2][4]. Share Consolidation - The company intends to consolidate its issued and outstanding common shares on a basis of ten pre-consolidation shares for one post-consolidation share [2]. - No fractional shares will be issued; any resulting fractions will be rounded to the nearest whole number [2]. - The effective date of the consolidation will be announced if the board considers it in the best interests of the company [3]. Private Placement - The company will seek approval for a private placement of up to 10,000,000 units, with each unit consisting of one common share and one transferable common share purchase warrant [4]. - Each warrant will allow the holder to acquire one additional common share for a period of 36 months from issuance, with the price to be determined later [4]. - All securities issued under the private placement will be subject to a statutory hold period of four months and one day following the closing [5]. Related Party Transactions - Certain directors and officers may acquire units under the private placement, which will be considered a related party transaction [6]. - The company plans to rely on exemptions from formal valuation and minority shareholder approval requirements for this related party participation, as the total value is not expected to exceed $2,500,000 [6]. Regulatory Compliance - The consolidation and private placement are subject to acceptance by the Canadian Securities Exchange (CSE) [9]. - The board reserves the right to revoke the resolutions approving the consolidation and private placement prior to implementation if deemed necessary [9]. Shareholder Voting - Shareholders of record on February 14, 2025, will be entitled to vote at the AGSM and will receive management's information circular and related proxy materials [10]. Company Overview - Metasphere Labs Inc. is a leading developer of Web3 and metaverse strategies, focusing on integrating blockchain technology into real-world applications with an emphasis on environmental sustainability and social impact [11].

Core Viewpoint - Helix BioPharma Corp. is extending its Annual General and Special Meeting to March 26, 2025, to secure shareholder approval for proposed asset acquisitions and financing arrangements [1][2]. Group 1: Meeting Details - The Annual General and Special Meeting has been rescheduled to March 26, 2025, to allow more time for shareholder approval regarding asset acquisitions from Laevoroc Immunology AG and Laevoroc Chemotherapy AG [1]. - The Ontario Superior Court of Justice approved the application to hold the Meeting by the new date on February 26, 2025 [2]. - Meeting materials, including the Notice of Meeting and Voting Instruction Form, were mailed to shareholders and posted on SEDAR+ on February 24, 2025 [3]. Group 2: Shareholder Participation - Shareholders of record as of January 31, 2025, are eligible to vote at the Meeting and are encouraged to vote in advance [4]. - Proxies must be received by 10 a.m. (EST) on March 24, 2025, to be counted [4]. Group 3: Company Overview - Helix BioPharma Corp. is focused on developing novel therapies for hard-to-treat cancers, with a pipeline that includes a proprietary technology platform targeting CEACAM6-expressing solid tumors [6]. - The lead candidate, Tumour Defence BreakerTM L-DOS47, is an antibody-enzyme conjugate that aims to enhance anti-cancer immunity and has completed Phase Ib studies in non-small cell lung cancer [6][7].

Core Insights - Headwater Gold Inc. announced successful results from its 2024 drill program at the Spring Peak project, significantly expanding high-grade mineralization and identifying new target zones for future drilling [1][2][3] Drilling Program Overview - The 2024 drill program involved 6,205 meters of drilling across 18 holes, focusing on new target areas and extensions of known mineralization along the Bear Fault corridor [3][4] - The program successfully confirmed high-grade gold in the new Shadow target and extended mineralization in the Southpaw target, indicating a strike extent of over one kilometer in the Bear Fault corridor [2][3][4] Key Target Areas - **Shadow Target**: Drill hole SP24-57 intersected 7.62 meters grading 3.55 g/t Au and 4.57 meters grading 3.16 g/t Au, including 1.52 meters at 7.67 g/t Au beneath a mercury-in-soil anomaly [4][6] - **Southpaw Target**: Drill holes SP24-52 and SP24-53 returned 4.75 g/t Au over 1.52 meters and 3.23 g/t Au over 1.52 meters, respectively, indicating strong mineralization in a significant step-out from the Disco Zone [4][10] - **Opal Ridge**: Anomalous gold was encountered in two drill holes, expanding the footprint of gold mineralization in the area [4][13] Mineralization Insights - The Bear Fault corridor, controlled by Headwater, has a strike extent of 15 kilometers, with drilling to date testing less than 1.5 kilometers, confirming high-grade mineralization and potential for parallel structures [4][10] - The presence of antimony and mercury associated with gold mineralization at depth serves as a critical tool for ongoing exploration efforts [6][10] Future Plans - The company plans to finalize the next phase of drilling to further explore and expand the high-grade mineralization footprint identified in the 2024 program [2][3]

Core Points - Helix BioPharma Corp. has extended its Annual General and Special Meeting to March 26, 2025, to seek shareholder approval for proposed asset acquisitions and financing [1][2] - The company has applied to the Ontario Superior Court for permission to hold the meeting by the new date, with a hearing scheduled for February 26, 2025 [2] - The Toronto Stock Exchange has acknowledged the extension, and the company plans to hold another annual general meeting before January 31, 2026 [3] Asset Acquisitions - The proposed asset acquisitions are from Laevoroc Immunology AG and Laevoroc Chemotherapy AG [1] - Additional information regarding these acquisitions can be found in the company's news releases dated November 29, December 2, and December 6, 2024 [4] Shareholder Participation - Shareholders of record as of January 31, 2025, are entitled to vote at the meeting, and they are encouraged to vote in advance using the provided instructions [5] - Proxies must be received by 10 a.m. (EST) on March 24, 2025 [5] Company Overview - Helix BioPharma Corp. is focused on developing novel therapies for hard-to-treat cancers, with a pipeline that includes a clinical-stage proprietary technology platform of bioconjugates targeting CEACAM6-expressing solid tumors [7] - The lead candidate, Tumour Defence BreakerTM L-DOS47, is an antibody-enzyme conjugate that aims to enhance anti-cancer immunity and has completed Phase Ib studies in non-small cell lung cancer [7]

Core Viewpoint - Nevis Brands Inc. has launched Happy Apple(™) Hemp Derived THC beverages, expanding its product line and market reach in the cannabis beverage sector [1][2]. Product Launch - Happy Apple is an infused beverage designed for relaxation without the hangover, previously available in Washington State and now expanding to multiple states across the U.S. [2] - The beverage uses a formulation that complies with federal laws by deriving THC from hemp, aligning with the 2018 Farm Bill which allows hemp products with less than 0.3% Delta-9 THC [3]. Market Potential - The hemp-derived cannabis beverage market generated $382 million in sales in 2024 and is projected to grow to nearly $750 million by 2029 [3]. - The introduction of Happy Apple allows Nevis to penetrate traditional retail markets, including liquor stores and supermarkets, as well as online sales [4]. Sales Strategy - Nevis is managing the sales and distribution of Happy Apple directly, which is a shift from its previous licensing model, enabling the company to capture a larger share of revenue [5][8]. - The company has launched direct sales platforms at DrinkHappyApple.com and NevisHemp.com, allowing consumers to purchase the product online [7][8]. Industry Positioning - Nevis Brands aims to capitalize on the growing trend of hemp-derived THC beverages, positioning itself for success in both dispensaries and traditional beverage channels [6].

Core Insights - SLAM Exploration Ltd. reported significant drilling results from the Goodwin copper nickel project, highlighting a 117.6 meter core interval grading 0.54% copper equivalent, including a high-grade zone of 17.1 meters grading 1.1% copper equivalent in hole GW24-15 [1][13] - The Logan, Farquharson, and Granges zones are identified as high-priority targets for the 2025 drilling campaign, with all zones open along strike and at depth [2][3] Drilling Results - The new high-grade zone in GW24-15 is the deepest intercept to date on the Logan zone, located 1,000 meters northwest of a previous high-grade intercept in the Farquharson zone [3] - The Logan zone shows increasing grades at depth, with significant intervals reported, including 2.00% copper equivalent over 64.9 meters in hole GW24-02 and 1.49% copper equivalent over 47.00 meters in hole GW24-03 [4][5][13] - The Farquharson zone has also shown increasing grades with depth, with core intervals ranging from 46 meters to 75 meters and grades from 0.75% to 1.26% copper equivalent [5][13] Project Expansion - The Goodwin project has been expanded to cover 11,450 hectares, extending 25 kilometers westward from the Bruce copper nickel occurrence, which was acquired in 2024 [10][13] - The project includes potential targets associated with gabbro intrusive bodies, indicating a promising mineralization environment [10][13] Upcoming Events - SLAM Exploration will participate in the PDAC Investors Exchange from March 2 to March 5, 2025, providing an opportunity to present the Goodwin Copper Nickel Project [11]

Core Points - CHARBONE HYDROGEN CORPORATION has nominated Mr. Jean-Claude Gonneau as a new Board member, to be elected at the Annual General and Extraordinary Meeting of Shareholders on March 28, 2025 [1] - Mr. Gonneau brings over 40 years of experience in management and investment banking, specializing in corporate and business development strategies in various sectors including technology, Greentech, and biotech [2][4] - The company has announced shares for debt settlements totaling $310,000 through the issuance of 4,133,334 common shares at a deemed value of $0.075 per share [5][6] - CHARBONE has amended its secured convertible debentures, increasing the total amount to $1,346,366 with a new annual interest rate of 12% and a conversion price of $0.10 per Debenture Share [7][8] - The company has granted 5,200,000 common share purchase options to directors and executives, allowing the purchase of shares at $0.15 per share for two years starting February 12, 2025 [9] - CHARBONE is focused on creating a network of modular green hydrogen production facilities across North America, producing eco-friendly dihydrogen for various users [10]